TD Asset Management
PMVP icon

TD Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History

TD Asset Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,600
Closed -$524K – 1531
2021
Q3 		$524K Sell
17,600
-1,200
-6% -$38.3K ﹤0.01% 1382
2021
Q2 		$639K Buy
+18,800
New +$628K ﹤0.01% 1356

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TD Asset Management's PMVP Position: Q4 2021 in Review

TD Asset Management sold out of PMV Pharmaceuticals (PMVP) in Q4 2021, closing a stake of 17,600 shares — an estimated $524K sold.

TD Asset Management first reported a position in PMVP in Q2 2021 and held it in 2 quarters. The position peaked at $639K in Q2 2021. 105 funds tracked by Wall St. Rank hold PMVP as of Q4 2021.

  • TD Asset Management reported no remaining PMV Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • TD Asset Management sold 17,600 PMV Pharmaceuticals shares in Q4 2021, an estimated $524K.
  • TD Asset Management first reported a position in PMV Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • TD Asset Management's PMV Pharmaceuticals position peaked at $639K in Q2 2021.
  • 105 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2021.

Based on TD Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.